Invesco S&P SmallCap Health Care ETF
Price through Oct 6, 2026 · Flows through Oct 5, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Oct 6, 2026. Holdings snapshot retrieved Oct 6, 2026.
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices, LLC compiles, maintains and calculates the index, which is designed to measure the performance of securities of small-capitalization U.S. companies in the health care sector, as defined by the Global Industry Classification Standard.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 3Y SHOWN · NET −$98M OVER THIS RANGE
Money keeps arriving — +$560K of net inflows over the past month, about 0.3% of the fund's asset base, while the price has returned +16.9% so far this year. At 0.29% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | GKOSGLAUKOS | 5.16% | $161.59 | -1.5% | ||
| 2 | PTGXPROTAGONIST THERAPEUTICS | 4.86% | $138.69 | -1.4% | ||
| 3 | TGTXTG THERAPEUTICS | 4.08% | $52.19 | -3.2% | ||
| 4 | ALKSALKERMES | 3.83% | $41.65 | -2.6% | ||
| 5 | LGNDLIGAND PHARMACEUTICALS | 3.26% | $296.94 | -3.2% | ||
| 6 | PTCTPTC THERAPEUTICS | 2.83% | $63.70 | +0.1% | ||
| 7 | TFXTELEFLEX | 2.83% | $124.74 | -0.4% | ||
| 8 | MMSIMERIT MEDICAL SYSTEMS | 2.78% | $84.96 | -2.5% | ||
| 9 | RDNTRADNET | 2.67% | $70.28 | -0.4% | ||
| 10 | CONCONCENTRA GROUP HOLDINGS PARENT INC | 2.29% | $36.40 | +0.5% | ||
| 11 | ITGRINTEGER HOLDINGS | 2.29% | $126.47 | +0.0% | ||
| 12 | INDVINDIVIOR | 2.27% | $35.90 | -0.3% | ||
| 13 | ICUIICU MEDICAL | 2.15% | $159.73 | -1.0% | ||
| 14 | AMRXAMNEAL PHARMACEUTICALS | 2.00% | $20.30 | -0.3% | ||
| 15 | OGNORGANON & | 1.92% | $13.74 | +0.3% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 66| 1 week | -1.1% |
| 1 month | -5.3% |
| 3 months | -5.0% |
| 6 months | +24.6% |
| YTD | +16.9% |
| 1 year | +20.9% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | −$2M |
| 1 month | +$560K |
| 3 months | +$20M |
| YTD | +$5M |
| 1 year | +$5M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 5.2% of the book; the top ten carry 35%. Spread across 71+ names, it behaves like roughly 47 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| SDGR SCHRODINGER | $1M | $5M |
| LQDA LIQUIDIA | $2M | $2M |
| ALHC ALIGNMENT HEALTHCARE | $841,313 | $844,026 |
| TGTX TG THERAPEUTICS | $391,036 | $236,049 |
| CERT CERTARA | $576,374 | $13,141 |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat PSCH on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41B | +$286M | -26bp on fee · 230× the assets · +$286M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -26bp on fee · 103× the assets · +$199M in over the month | Head-to-head |
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $123.5B | +$2.3B | -24bp on fee · 694× the assets · +$2.3B in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.4B | +$497M | -25bp on fee · 182× the assets · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.3B | +$575M | -25bp on fee · 131× the assets · +$575M in over the month | Head-to-head |